menu search

Black diamond therapeutics presents dose escalation data demonstrating durable responses in patients with nsclc from phase 1 trial of bdtx-1535

Initial results from BDTX-1535 dose escalation show durable activity in patients with NSCLC across heterogeneous EGFR mutation subtypes No new safety ...

October 14, 2023, 4:30 pm

Cogent biosciences presents preclinical data highlighting precision oncology pipeline at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics

– Novel selective and reversible FGFR2 inhibitor exhibits strong potency across key primary and resistance driver mutations with potential advantage...

October 14, 2023, 4:30 pm

Prelude announces multiple clinical and preclinical poster presentations at aacr-nci-eortc international conference 

WILMINGTON, Del. and BOSTON, Oct. 14, 2023 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD), a clinical-stage pre...

October 14, 2023, 4:30 pm

Mid-october 2023 watchlist: leading ancillary cannabis stocks

The cannabis industry's landscape is still changing at an incredibly fast rate as we approach mid-October 2023. The ancillary business has become a ho...

October 14, 2023, 3:00 pm

Morphic holding shareholder alert: johnson fistel encourages morphic holding shareholders with losses to contact the firm regarding investigation

SAN DIEGO, Oct. 13, 2023 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Morphic...

October 13, 2023, 11:51 pm

Travere therapeutics to present abstracts at the american society of nephrology (asn) kidney week 2023

Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsenta...

October 13, 2023, 8:30 pm

Stronghold announces bitcoin mining update and frontier managed services agreement

NEW YORK, Oct. 13, 2023 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Stronghold”, or the “Company”) today provided th...

October 13, 2023, 8:30 pm

Mineralys therapeutics announces upcoming poster presentations at two scientific conferences in november 2023

Late-breaking poster presentation at ASN’s Kidney Week 2023 – – –Poster presentation at AHA’s Scientific Sessions 2023 RADNOR, Pa., Oct. 13,...

October 13, 2023, 8:10 pm

Graphic packaging (gpk) ascends while market falls: some facts to note

The latest trading day saw Graphic Packaging (GPK) settling at $20.93, representing a +0.34% change from its previous close....

October 13, 2023, 7:33 pm

Nokia (nok) suffers a larger drop than the general market: key insights

The latest trading day saw Nokia (NOK) settling at $3.51, representing a -1.68% change from its previous close....

October 13, 2023, 7:32 pm

Why rockwell medical (rmti) dipped more than broader market today

The latest trading day saw Rockwell Medical (RMTI) settling at $1.97, representing a -0.51% change from its previous close....

October 13, 2023, 7:32 pm

Alnylam pharmaceuticals: a good buy ahead of phase 3 data for vutrisiran

We rate Alnylam Pharmaceuticals, Inc.'s common stock a Buy on the dip after the complete response letter, CRL for Patisiran. The investment thesis is ...

October 13, 2023, 6:11 pm

Processa pharmaceuticals to present at the thinkequity conference

HANOVER, MD, Oct. 13, 2023 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage ...

October 13, 2023, 5:08 pm

Kronos bio presents positive preliminary data from phase 1 dose escalation portion of phase 1/2 kb-0742 study at aacr-nci-eortc

Demonstrated on-mechanism, single agent anti-tumor activity in heavily pre-treated patients with transcriptionally addicted solid tumors Showed manage...

October 13, 2023, 4:30 pm

Travere therapeutics to present abstracts at the american society of nephrology (asn) kidney week 2023

Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI ® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsent...

October 13, 2023, 4:30 pm

Canada goose: undervalued luxury

Luxury conglomerates are struggling with demand overhang as consumers pulled forward purchases into the pandemic period. Canada Goose stock has declin...

October 13, 2023, 4:29 pm

Revolution medicines presents encouraging clinical data for rmc-6236 and rmc-6291 at 2023 triple meeting

Clinical dose escalation data for RMC-6236, a RASMULTI(ON) Inhibitor, show oral bioavailability, well-tolerated safety profile and preliminary evidenc...

October 13, 2023, 3:50 pm

Weyerhaeuser and west fraser lead the pack in timber/lumber

Timber REITs are trading at discounts to their asset value, presenting buying opportunities. Investment in timber REITs involves different segments wi...

October 13, 2023, 2:51 pm

Vera therapeutics to present three posters at the american society of nephrology kidney week 2023 annual meeting

Informational poster for ORIGIN 3 Pivotal Phase 3 study evaluating atacicept in IgA Nephropathy (IgAN) Additional analysis of week 36 data from Phase ...

October 13, 2023, 2:22 pm

Outsmart the market with these 3 ai picks-and-shovels stocks

Every emerging sector has its picks-and-shovels stocks that represent the crucial tools and equipment n...

October 13, 2023, 1:50 pm


Search within

Pages Search Results: